ACM
NEO icon

Altium Capital Management’s NeoGenomics NEO Stock Holding History

Altium Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-240,000
Closed -$4.18M – 85
2023
Q1 		$4.18M Sell
240,000
-45,000
-16% -$641K 2.32% 14
2022
Q4 		$2.63M Buy
+285,000
New +$2.66M 1.34% 31

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altium Capital Management's NEO Position: Q2 2023 in Review

Altium Capital Management sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 240,000 shares — an estimated $4.18M sold.

Altium Capital Management first reported a position in NEO in Q4 2022 and held it in 2 quarters. The position peaked at $4.18M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Altium Capital Management reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Altium Capital Management sold 240,000 NeoGenomics shares in Q2 2023, an estimated $4.18M.
  • Altium Capital Management first reported a position in NeoGenomics in Q4 2022 and held it in 2 quarters.
  • Altium Capital Management's NeoGenomics position peaked at $4.18M in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.